Home » Topics » Regulatory » EMA

EMA
RSS

Takeda withdraws new European Rienso submission

March 2, 2015

EMA committee recommends new approval of Vectibix in metastatic colorectal cancer

March 2, 2015

EMA's CHMP backs approval of Jinarc for rare kidney disease

March 2, 2015

CHMP recommends conditional marketing approval of ceritinib

March 2, 2015

EMA awards orphan drug designation to alvocidib for AML

Feb. 26, 2015

EMA grants orphan drug status to Theravectys vaccine for ATL/L

Feb. 9, 2015

Amgen and Onyx file applications to expand approval of carfilzomib in the E.U. and U.S.

Jan. 28, 2015

EMA adopts positive opinion on Ikervis eye drops

Jan. 27, 2015

EMA grants orphan drug designation to ApoCell for GVHD

Jan. 27, 2015

EMA CHMP recommends approval of lamivudine/raltegravir for HIV-1 infection

Jan. 27, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Kymera’s IRF5 degrader shows potential in IBD treatment
BioWorld Science
At the recently concluded Digestive Disease Week, researchers from Kymera Therapeutics Inc. presented preclinical efficacy data on KT-579, a selective oral IRF5...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...